H-Arg-Gln-OH hydrochloride salt

Names

[ Name ]:
H-Arg-Gln-OH hydrochloride salt

[Synonym ]:
L-Arginyl-L-glutamin-acetat
Arginylglutamine
Glutamine,N2-L-arginyl-(6CI,7CI)
L-Arg-L-Gln
L-Glutamine,N2-L-arginyl
L-Glutamine,L-arginyl
Glutamine,N2-L-arginyl-,L-(8CI)
N2-L-Arginyl-L-glutamin
N2-L-arginyl-L-glutamine
L-Arginyl=>L-glutamin
L-arginyl-L-glutamine
H-ARG-GLN-OH

Biological Activity

[Description]:

Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

[Related Catalog]:

Research Areas >> Cardiovascular Disease

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> VEGFR

[Target]

VEGF[1]

[In Vitro]

Arginyl-Glutamine (0.5-1.5 mM; 48 h) 会导致人类 RPE 细胞中可溶性 VEGF 在培养基中的表达呈统计学意义上的剂量依赖性下降[1]。

[In Vivo]

Arginyl-Glutamine (1-5 g/kg/day as a hydrochloride salt; i.p.; twice daily) 显著抑制小鼠氧诱导视网膜病变 (OIR) 模型中的视网膜新生血管[1]。 Animal Model: C57BL6/J mouse pups, oxygen-induced retinopathy (OIR) model[1] Dosage: 1.0, 2.5, or 5 g/kg per day Administration: Intraperitoneal injection, twice daily Result: Significantly decreased preretinal nuclei. Reduced neovascular tufts and vascular leakage in retinal vessels. Reduced preretinal neovascularization by 82% ± 7% and reduced VEGF mRNA by 64% ± 9% at 5 g/kg per day.

[References]

[1]. Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3151-5.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₁H₂₂N₆O₄

[ Molecular Weight ]:
302.33

[ Exact Mass ]:
338.14700

[ PSA ]:
197.41000

[ LogP ]:
1.19630

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.